Related Advisory Committees
Related Advisory Committees

2017 Policy Agenda
(Extract on development of Chinese medicine)

Chapter 4 - Medical Services, Public Health and Elderly Care

New Initiatives
Chinese Medicine

  • Prepare to finance the construction of a Chinese medicine hospital on a reserved site in Tseung Kwan O and invite the HA to assist in identifying by way of tender a suitable non-profit-making organisation to take forward and operate the hospital. (FHB)

  • Continue to implement and expand the Integrated Chinese-Western Medicine Pilot Project through the HA. (FHB)

On-going Initiatives
Chinese Medicine

  • Implementing the Integrated Chinese-Western Medicine Pilot Project to gather experience in the operation of integrated Chinese-Western medicine and Chinese medicine in-patient services, which will serve as the basis for formulating the mode of operation of a Chinese medicine hospital. Launched in September 2014, the pilot project provides treatment with integrated Chinese-Western medicine for three disease areas, namely stroke treatment, low back pain care and palliative care for cancer, in seven hospitals of the HA. (FHB)

  • Conducting a review of the development of the Chinese medicine sector through the Chinese Medicine Development Committee established in February 2013 to formulate a strategy to raise the professional standard and status of Chinese medicine practitioners, support research and development of Chinese medicine, promote treatment with integrated Chinese-Western medicine, expand the role of Chinese medicine in the public healthcare system, and examine the feasible mode of operation of a Chinese medicine hospital. (FHB)

  • Continuing to subsidise and monitor the 18 public Chinese medicine clinics to enhance Chinese medicine service in our public healthcare system. (FHB)

  • Planning and developing the Government Chinese Medicines Testing Institute through the DH. The Institute will specialise in the testing of and scientific research on Chinese medicines, with a view to setting reference standards for the safety, quality and testing methods of Chinese medicines. Pending the establishment of a permanent Government Chinese Medicines Testing Institute, we will set up a temporary one, which will be operated in phases from the first quarter of 2017. (FHB)

  • Continuing with the research work after completing the compilation of Hong Kong Chinese Materia Medica Standards for 236 Chinese materia medica commonly used in Hong Kong. Our target is to set reference standards for around 28 Chinese materia medica each year. A pilot study has also been launched on the standard setting for Chinese medicines decoction pieces under the Hong Kong Chinese Materia Medica Standards Project. (FHB)

(Full Document of 2017 Policy Agenda)



Back Top

2017Copyright| Important notices | Privacy Policy

Last revision date:20/01/2017